[ad_1]
One person dies of coronavirus at Moderna Research
The American coronavirus vaccine has been shown to be 100% effective when used in patients with severe coronavirus.
The mRNA-1273 coronavirus vaccine from the American company Moderna has demonstrated the drug’s efficacy at 100 percent level in severe COVID-19. More than 30,000 volunteers participated in the drug trial, according to a press release on the company’s website.
In other cases, the effectiveness of the vaccine was 94.1 percent. Most of the participants during drug trials underwent vaccination without noticeable consequences.
In total, more than 30 thousand people participated in the tests. Of these, 196 people who received a placebo and 11 people who received the vaccine became ill with the coronavirus. In this case, the company concludes, the effectiveness of the vaccine was 94.1%.
During the trial, 30 volunteers contracted severe COVID-19; These are people who received a placebo instead of a vaccine. Of those who received the vaccine, none were seriously ill, indicating that the vaccine is 100% effective.
It is also known that during Moderna’s investigation, a person who was part of the placebo group died of coronavirus.
“This positive initial analysis confirms the ability of our vaccine to prevent COVID-19 disease with an efficacy of 94.1 percent, as well as the ability to prevent serious diseases. We believe that our vaccine will be a powerful new tool that can change the course of the pandemic “. Press release.
Moderna also said the company is applying for vaccine registration in the United States.
Korrespondent.net also wrote that the EU will enter into a contract with Moderna for 160 million doses of the vaccine. Once the vaccine is shown to be effective and safe, all EU countries will receive it on equal terms.
Before that, it emerged that the United States had asked for a “fair” price for Moderna’s COVID vaccine.
News of Correspondent.net on Telegram. Subscribe to our channel https://t.me/korrespondentnet
